For many women, heavy menstrual bleeding and associated pain are more than just an inconvenience—they can significantly disrupt daily life, impacting physical health, mental well-being, and social activities. Now, a fresh option is available at Helios Klinikum Uelzen, offering a less invasive alternative to traditional treatments. The clinic is now offering NovaSure, a procedure also known as the “gold net” method, to effectively manage and potentially eliminate heavy periods.
The NovaSure procedure works by reducing or even stopping menstrual bleeding. Historically, managing heavy periods involved hormonal treatments like birth control pills, or, in more severe cases, hysterectomy—surgical removal of the uterus. This new approach, completed in as little as 90 seconds on an outpatient basis, promises a quicker recovery and less disruption to a woman’s life. The procedure is minimally invasive, aiming for a gentler experience for patients seeking relief from debilitating menstrual cycles. This innovative treatment for starke Regelblutungen, or heavy menstrual bleeding, is gaining traction as a viable option for many.
“With NovaSure, People can help women who suffer from heavy menstrual bleeding much more easily than before and craft their everyday lives easier,” says Thomas Köster, Chief Physician of Gynecology and Obstetrics at Helios Klinikum Uelzen. “We are pleased to be able to offer this gentle method at our clinic.”
How NovaSure Works and Who It’s For
According to data from Helios Klinikum Uelzen, approximately 60 percent of women who undergo the NovaSure procedure experience a complete cessation of menstrual bleeding. Others report significantly lighter periods. The procedure involves the placement of a mesh, made of a gold-like material, within the uterus to reduce bleeding. However, it’s crucial to understand that NovaSure is not a suitable option for all women. Because pregnancy is no longer possible or is not recommended after the treatment, it is specifically intended for women who have completed their family planning.
A thorough preliminary examination is essential to determine if a woman is a suitable candidate for the NovaSure procedure. This evaluation ensures the treatment is tailored to the individual’s specific needs and medical history. Further information about the procedure and suitability can be found on the Helios Klinikum Uelzen website.
The Rise of Minimally Invasive Treatments for Menstrual Disorders
The introduction of NovaSure at Helios Klinikum Uelzen reflects a broader trend toward minimally invasive treatments for gynecological conditions. Traditional approaches, such as hysterectomy, while effective, carry longer recovery times and potential complications. NovaSure, along with other methods like MyoSure (another minimally invasive option for removing polyps and fibroids, mentioned on the Helios website), offers women more choices and the potential for a faster return to normal activities.
The demand for less invasive options is driven by a growing awareness of the impact of heavy menstrual bleeding on quality of life. Symptoms extend beyond physical discomfort, often leading to fatigue, anemia, and emotional distress. Finding effective and convenient solutions is therefore a priority for many women and healthcare providers.
Fresenius Helios: A Leading Healthcare Provider
Helios Klinikum Uelzen is part of Fresenius Helios, a leading private healthcare provider in Europe. According to information provided by Helios, the organization serves approximately 27 million people annually across around 140 clinics and numerous outpatient facilities. In 2025, Fresenius Helios reported a total revenue exceeding 13.5 billion euros.
In Germany alone, Helios operates more than 80 clinics, around 200 Medical Care Centers (MVZ), six prevention centers, and 30 occupational health centers. The group treated around 5.6 million people in Germany in 2025, with over 4 million receiving outpatient care. Helios emphasizes its commitment to measurable, high medical quality and data transparency, consistently exceeding national averages in over 90 percent of quality targets. The organization employs approximately 80,000 people in Germany and generated a revenue of around 8.1 billion euros in 2025.
Looking Ahead: Expanding Access to Innovative Treatments
The availability of NovaSure at Helios Klinikum Uelzen represents a significant step forward in providing women with more options for managing heavy menstrual bleeding. As the procedure becomes more widely adopted, it has the potential to improve the quality of life for countless women who have previously struggled with this common but often debilitating condition. Helios Klinikum Uelzen will continue to evaluate and integrate innovative technologies to provide the best possible care for its patients.
If you are experiencing heavy menstrual bleeding, it’s vital to discuss your symptoms with your healthcare provider to determine the most appropriate treatment plan.
Disclaimer: This article provides general information and should not be considered medical advice. Please consult with a qualified healthcare professional for personalized guidance and treatment options.
What are your thoughts on this new treatment option? Share your comments below, and please share this article with anyone who might discover it helpful.
